
Sacubitril 49 mg + Valsartan 51 mg | Heart Failure Medicine | Pharmaceutical Exporter from Nagpur, India
Phoenix Exim is a pharmaceutical exporter based in Nagpur, India, offering pharmaceutical products for international B2B requirements and supporting supply inquiries for markets including USA, UK, Australia, Singapore, Canada, South Korea, and UAE, subject to applicable regulatory and import requirements.
1. π GENERAL INFORMATION
Sacubrook V 100 mg is a prescription cardiovascular medicine containing a combination of Sacubitril 49 mg and Valsartan 51 mg.
It belongs to the angiotensin receptor neprilysin inhibitor (ARNI) class and is used as part of the management of certain patients with chronic heart failure.
The two active ingredients work through complementary mechanisms to support cardiovascular function and reduce strain on the heart.
Important: Sacubrook V 100 mg should be taken only under the direction of a qualified healthcare professional. It is not intended for self-medication.
2. π PRODUCT INFORMATION
| Product Detail | Information |
|---|---|
| Brand | Sacubrook V |
| Strength | 100 mg |
| Composition | Sacubitril 49 mg + Valsartan 51 mg |
| Dosage Form | Tablet |
| Therapeutic Category | Cardiovascular / Heart Failure |
| Drug Class | ARNI |
| Route | Oral |
| Primary Use | Management of certain types of chronic heart failure |
| Country of Origin | India |
| Exporter | Phoenix Exim |
| Supply Location | Nagpur, Maharashtra, India |
The 100 mg strength represents the combined amount of the two active ingredients: 49 mg sacubitril + 51 mg valsartan.
3. β€οΈ USES OF SACUBROOK V 100 MG
Sacubitril/valsartan is prescribed for the management of certain forms of chronic heart failure, depending on the patient's condition and applicable clinical guidelines.
πΉ Heart Failure Management
It helps reduce the workload on the heart and supports cardiovascular function in appropriate patients.
πΉ Reduced Risk of Heart-Failure Events
In suitable patients, sacubitril/valsartan can reduce the risk of cardiovascular death and hospitalization related to heart failure.
πΉ Support for Long-Term Cardiovascular Care
It may form part of a comprehensive heart-failure treatment plan alongside other medicines and lifestyle measures recommended by a healthcare professional.
The exact indication and eligibility depend on the patient's age, heart function, blood pressure, kidney function, potassium levels, and other clinical factors.
4. β KEY BENEFITS
When appropriately prescribed and monitored, Sacubrook V 100 mg may provide important cardiovascular benefits:
β
Supports management of chronic heart failure
β
Helps reduce strain on the heart
β
Supports improved cardiovascular function
β
May reduce the risk of heart-failure hospitalization
β
May reduce cardiovascular mortality in appropriate patients
β
Combines two complementary mechanisms in one tablet
β
Convenient fixed-dose combination therapy
β
Can form part of a comprehensive heart-failure treatment regimen
Treatment benefits vary between patients and depend on appropriate medical supervision and adherence to the prescribed regimen.
5. β οΈ SIDE EFFECTS
Like all prescription medicines, Sacubitril/Valsartan can cause side effects.
Possible adverse effects include:
Low blood pressure (hypotension)
Dizziness
Increased potassium levels (hyperkalemia)
Changes in kidney function
Cough
Headache
Diarrhea
Fatigue
A serious but uncommon reaction is angioedema, which can cause swelling of the face, lips, tongue, or throat and may interfere with breathing.
Seek urgent medical attention if severe swelling or breathing difficulty occurs.
6. πΈ COMMON SIDE EFFECTS
Some commonly reported effects may include:
Dizziness β’ Low Blood Pressure β’ Increased Potassium β’ Changes in Kidney Function β’ Cough β’ Headache β’ Diarrhea β’ Fatigue
Dizziness or light-headedness may be more noticeable when treatment is started or when the dose is changed.
Regular medical monitoring may be recommended, particularly for blood pressure, kidney function, and potassium levels.
7. π HOW TO USE SACUBROOK V 100 MG
Take Sacubrook V 100 mg exactly as prescribed by your healthcare professional.
General Administration Guidelines
STEP 1 β Take as Prescribed
Take the prescribed dose at the recommended time.
STEP 2 β Oral Administration
Swallow the tablet with water.
STEP 3 β Consistency Matters
Try to take it at approximately the same time each day.
STEP 4 β With or Without Food
Sacubitril/valsartan may generally be taken with or without food.
STEP 5 β Do Not Self-Adjust
Do not increase, reduce, or stop the dose without medical advice.
Missed Dose
If you miss a dose, follow the instructions provided by your healthcare professional or the approved product information. Do not take extra doses to compensate unless specifically instructed.
8. βοΈ HOW DOES SACUBROOK V 100 MG WORK?
Sacubrook V contains two active ingredients that work through complementary pathways.
π¬ Sacubitril
Sacubitril is converted in the body to an active metabolite that inhibits neprilysin.
This helps increase the availability of naturally occurring peptides involved in processes such as:
Natriuresis
Vasodilation
Reduction of cardiac workload
Regulation of fluid balance
π« Valsartan
Valsartan is an angiotensin II receptor blocker (ARB).
It blocks the effects of angiotensin II at the AT1 receptor, helping reduce:
Vasoconstriction
Sodium and water retention
Excessive activation of the renin-angiotensin-aldosterone system
π Combined Action
Together, sacubitril and valsartan provide complementary effects that help reduce cardiovascular strain and support the management of appropriate heart-failure patients.
9. π‘οΈ SAFETY ADVICE
βοΈ Prescription Medicine
Use only under the supervision of a qualified healthcare professional.
π©Ί Monitor Blood Pressure
Because the medicine can lower blood pressure, dizziness or light-headedness may occur.
π§ͺ Kidney Function & Potassium
Healthcare professionals may monitor kidney function and blood potassium levels during treatment.
π« Avoid ACE Inhibitors Together
Sacubitril/valsartan should not be taken together with an ACE inhibitor because of the increased risk of angioedema.
A healthcare professional will generally ensure an appropriate interval when switching between an ACE inhibitor and sacubitril/valsartan.
π Be Careful With Other Medicines
Tell your healthcare professional about all medicines and supplements you take, particularly:
ACE inhibitors
Other ARBs
Potassium supplements
Potassium-containing salt substitutes
Potassium-sparing diuretics
NSAIDs
Other blood-pressure-lowering medicines
π€° Pregnancy
Sacubitril/valsartan can harm an unborn baby. Tell your healthcare professional immediately if you are pregnant or become pregnant during treatment.
πΌ Breastfeeding
Discuss treatment with your healthcare professional if you are breastfeeding.
π¨ Angioedema
Seek urgent medical attention for swelling of the face, lips, tongue, or throat, particularly if breathing or swallowing becomes difficult.
πΊ Alcohol
Alcohol may worsen dizziness or low blood pressure in some people. Discuss alcohol use with your healthcare professional.
π¦ Storage
Store according to the manufacturer's instructions and keep out of reach of children.
10. β FREQUENTLY ASKED QUESTIONS
Q1. What is Sacubrook V 100 mg?
Sacubrook V 100 mg is a prescription tablet containing Sacubitril 49 mg + Valsartan 51 mg.
Q2. What is Sacubrook V 100 mg used for?
It is used as part of the management of certain patients with chronic heart failure.
Q3. What does the 100 mg strength mean?
The 100 mg tablet contains 49 mg sacubitril + 51 mg valsartan, giving a combined active-ingredient strength of 100 mg.
Q4. Is Sacubrook V a blood-pressure medicine?
Valsartan has blood-pressure-lowering effects, but the sacubitril/valsartan combination is primarily used as a cardiovascular medicine for appropriate heart-failure patients.
Q5. Can Sacubrook V lower blood pressure?
Yes. Low blood pressure can occur as a side effect, particularly in susceptible patients.
Q6. Does Sacubrook V affect the kidneys?
It can affect kidney function in some patients. Healthcare professionals may monitor kidney function during treatment.
Q7. Can Sacubrook V increase potassium?
Yes. Hyperkalemia, or elevated blood potassium, can occur. Potassium levels may therefore require monitoring.
Q8. Can Sacubrook V be taken with an ACE inhibitor?
No. Sacubitril/valsartan should not be taken simultaneously with an ACE inhibitor because of the increased risk of angioedema. Appropriate switching instructions should come from a healthcare professional.
Q9. Can Sacubrook V be stopped suddenly?
Do not stop prescribed heart-failure treatment without consulting your healthcare professional.
Q10. Is Sacubrook V 100 mg available for international B2B supply?
International availability, prescription status, registration, import eligibility, labeling, documentation, and customs requirements vary by destination country. Buyers should verify all applicable requirements before purchasing.
11. π SUBSTITUTE / ALTERNATIVES
The closest pharmaceutical alternatives are other approved sacubitril/valsartan formulations with equivalent active-ingredient strengths, where legally available.
Potential alternatives may include:
Sacubitril 49 mg + Valsartan 51 mg tablets from another approved manufacturer
Other approved sacubitril/valsartan strengths, when clinically appropriate
Other guideline-directed heart-failure medicines, when prescribed by a healthcare professional
β οΈ Important
Different strengths are not automatically interchangeable. A different heart-failure medicine is also not necessarily a direct substitute.
Any change in product, strength, or treatment regimen should be determined by a qualified healthcare professional.
12. π SEO KEYWORDS
π Primary Product Keywords
Sacubrook V 100 mg
Sacubrook V 100 mg Tablets
Sacubrook V 100 mg exporter
Sacubrook V supplier India
Sacubitril 49 mg Valsartan 51 mg
Sacubitril Valsartan 100 mg tablets
Sacubitril Valsartan supplier
Sacubitril Valsartan exporter India
Sacubitril Valsartan pharmaceutical supplier
Sacubitril Valsartan tablets exporter
π B2B & Export Keywords
Sacubitril Valsartan exporter from India
Sacubitril Valsartan pharmaceutical supplier India
Sacubrook V pharmaceutical exporter
Heart failure medicine supplier India
Cardiovascular medicine exporter India
Sacubitril Valsartan B2B supplier
Sacubitril Valsartan wholesale supplier
Cardiovascular pharmaceutical supplier Nagpur
Sacubitril Valsartan international supplier
Heart failure medicine exporter India
π Country-Focused Keywords
Sacubitril Valsartan supplier USA
Sacubitril Valsartan supplier UK
Sacubitril Valsartan supplier Australia
Sacubitril Valsartan supplier Canada
Sacubitril Valsartan supplier Singapore
Sacubitril Valsartan supplier South Korea
Sacubitril Valsartan supplier UAE
India pharmaceutical exporter USA
India pharmaceutical exporter UK
India pharmaceutical exporter Australia
India pharmaceutical exporter Canada
India pharmaceutical exporter Singapore
India pharmaceutical exporter South Korea
India pharmaceutical exporter UAE
Nagpur pharmaceutical exporter
π₯ Long-Tail SEO Keywords
Sacubrook V 100 mg pharmaceutical exporter from India
Sacubitril 49 mg Valsartan 51 mg tablet supplier
Sacubitril Valsartan 100 mg international B2B supplier
Sacubitril Valsartan heart failure medicine exporter
Sacubrook V 100 mg supplier from Nagpur India
Sacubitril Valsartan cardiovascular medicine supplier
Heart failure pharmaceutical product exporter India
Sacubitril Valsartan international supply partner
Sacubitril Valsartan tablets B2B pharmaceutical supplier
Cardiovascular medicine exporter from Nagpur India
π’ Phoenix Exim Keywords
Phoenix Exim pharmaceutical exporter
Phoenix Exim medicine exporter Nagpur
Phoenix Exim Sacubrook V supplier
Phoenix Exim Sacubitril Valsartan supplier India
Phoenix Exim cardiovascular medicine exporter
π PHOENIX EXIM β INTERNATIONAL PHARMACEUTICAL SUPPLY
Sacubrook V 100 mg | Sacubitril 49 mg + Valsartan 51 mg
Phoenix Exim
Pharmaceutical & Cardiovascular Product Exporter from Nagpur, India
π International B2B Supply Support:
πΊπΈ USA | π¬π§ UK | π¦πΊ Australia | πΈπ¬ Singapore | π¨π¦ Canada | π°π· South Korea | π¦πͺ UAE
Keywords







